The Centre for Biotechnology Research and Development (CBRD) is one of the research centers of the Kenya Medical Research Institute (KEMRI). The Centre is located within the KEMRI Headquarters complex in Nairobi.

The Centre for Biotechnology Research and Development (CBRD) is one of the research centers of the Kenya Medical Research Institute (KEMRI). The Centre is located within the KEMRI Headquarters complex in Nairobi.


  • To improve human health and quality of life through
    research, capacity building innovation and service delivery


To be a leading Centre of excellence in research for

human health


To apply modern science and biotechnology to discover, develop and improve tools and strategies for diagnosis, prevention and control of major human diseases in Kenya and the region

  1. To improve our basic understanding of the biology of disease causing agents of public health importance in Kenya and the region, including their responses to intervention (e.g. drugs or vaccines), host responses and diseases processes (e.g. immunity, pathogenesis, patho-physiology, host-pathogen interactions), and disease epidemiology.

In addition, the Centre co-ordinates and advises on issues related to basic biomedical and biotechnological research, pre-clinical studies, quality control and bio-safety. The Centre also provides specialized laboratory services and expertise to the scientific community and the general public. It also mentors, trains and supervises both undergraduate and post-graduate students from local colleges and universities. 


  • Current research in the Centre focuses on HIV/AIDS, malaria, schistosomiasis, leishmaniasis, and lymphatic filariasis. Research expertise includes molecular parasitology, molecular entomology, cellular immunology, biotechnology, biochemistry, and malacology.

    Broadly speaking, research in CBRD aims to develop and improve diagnostic assays, to understand immune responses and disease processes, to characterize pathogens and their responses to chemotherapeutic interventions, to understand vector biology and ecology, develop strategies for pathogen and vector control, and to exploit biodiversity for the discovery of new drugs against diseases.

1. Leshmainia Section

2. Schistosomiasis Section

3. Malaria section

4. Animal House

5. Molecular Entomology & Ecology Section

6. HID Lab

CBRD offers the following specialized services to interested researchers, institutions or the general public:

  1. Analysis of CD4/CD8 T-cells in HIV/AIDS as a service to the scientific community and to the general public,
  2. Training in flow cytometry technology,
  3. Training of university undergraduate and polytechnic students on industrial attachment,
  4. Research training for university post-graduate students,
  5. Supply vertebrate animals (mice, hamsters, guinea pigs) for research or teaching purposes to interested researchers or institutions.
  • Stem Cell Research which seeks to develop new diagnostic and therapeutic tools for cancer and diabetes with the goal of reducing the economic burden of medical care, thus making it more accessible
  • Lymphatic filariasis research involving epidemiological surveys on Lymphatic filariasis in Coastal Kenya to determine the impact of Mass Drug Administration (MDA) in this Lymphatic filariasis endemic area and development of a new Point of Care (POC) diagnostic kit for Lymphatic filariasis for use in the resource limited settings.
  • Malaria Research involving malaria prevalence studies and surveillance for antimalarial and insecticide efficacy and resistance in Kenya so as to inform policies on malaria control and treatment through provision of quality data to ensure that only quality and effective antimalarials and insecticides are in use. Additional research is in the development of new malaria diagnostic tools and of novel antimalarial and insecticidal compounds.
  • Leishmaniasis Research includes disease surveillance and epidemiological studies with the goal of identifying new foci of leishmaniasis transmission and thus control to reduce disease transmission, evaluation of anti-leishmania activity of a novel compound in the mouse model and in vitro and anti-leishmaniasis vaccine studies.

Schistosomiasis Research involves disease surveillance to determine areas where schistosomiasis treatment coverage should be increased as well as development of new more sensitive and cost-effective tools for schistosomiasis diagnosis and control.

contact us

Kenya Medical Research Institute

Centre for global health research

P.O Box 20778-00202 Kisumu Tel: +254 020 2726781

+254 020 2722541, +254 020 2713349, 0722205901


Email: cghr@kemri.org

Your Name (required)

Your Email (required)


Your Message